Holen Sie sich die Stockscreener-App
37.30
0.64%
-0.24
Handel nachbörslich:
37.30
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
Can Royalty Pharma plc stock rebound after recent weakness2025 Market Sentiment & Fast Moving Trade Plans - newser.com
What To Expect From Royalty Pharma’s (RPRX) Q3 Earnings - Yahoo! Finance UK
Royalty Pharma PLC $RPRX is Torray Investment Partners LLC's 3rd Largest Position - MarketBeat
Tredje AP fonden Increases Stake in Royalty Pharma PLC $RPRX - MarketBeat
Will Royalty Pharma plc (RPD) stock maintain strong growthPortfolio Return Report & Community Trade Idea Sharing - newser.com
Will Royalty Pharma plc (RPD) stock hit Wall Street targetsJobs Report & Weekly Breakout Opportunity Watchlist - newser.com
Is Royalty Pharma plc stock a top momentum playWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com
What the charts say about Royalty Pharma plc today2025 Price Momentum & Scalable Portfolio Growth Methods - newser.com
Why Royalty Pharma plc (RPD) stock could outperform next year2025 Technical Overview & Safe Entry Trade Signal Reports - newser.com
Why Royalty Pharma plc (RPD) stock could rally stronglyStock Surge & Long-Term Safe Investment Plans - newser.com
What MACD signals say about Royalty Pharma plcMarket Movement Recap & Low Risk Investment Opportunities - newser.com
8,849 Shares in Royalty Pharma PLC $RPRX Acquired by MMA Asset Management LLC - MarketBeat
Royalty Pharma PLC $RPRX is Regal Partners Ltd's 9th Largest Position - MarketBeat
Top chart patterns to watch in Royalty Pharma plcStock Surge & Risk Managed Investment Strategies - newser.com
Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Loss Report & Reliable Intraday Trade Plans - newser.com
Applying chart zones and confluence areas to Royalty Pharma plcInsider Buying & Short-Term High Return Ideas - newser.com
Royalty Pharma plc : Close to an important technical resistance levels - MarketScreener
Why analysts remain bullish on Royalty Pharma plc stockEarnings Trend Report & AI Enhanced Trading Alerts - newser.com
Historical volatility pattern of Royalty Pharma plc visualizedLong Setup & Risk Controlled Swing Alerts - newser.com
Can Royalty Pharma plc stock beat analyst upgradesProfit Target & Fast Gain Swing Trade Alerts - newser.com
Detecting support and resistance levels for Royalty Pharma plcMarket Trend Report & Fast Entry Momentum Alerts - newser.com
How Royalty Pharma plc (RPD) stock performs in easing cycles2025 Market Trends & Growth Focused Stock Pick Reports - newser.com
28,646 Shares in Royalty Pharma PLC $RPRX Bought by Nisa Investment Advisors LLC - MarketBeat
How Royalty Pharma Prints Cash Without Biotech's Biggest Risks - MSN
Using Python tools to backtest Royalty Pharma plc strategiesMarket Trend Report & Stock Portfolio Risk Control - newser.com
Quantitative breakdown of Royalty Pharma plc recent moveWall Street Watch & Risk Managed Investment Signals - newser.com
Royalty Pharma (NASDAQ:RPRX) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
What drives Royalty Pharma plc stock priceMarket Sentiment Extremes & Low Risk Trading Ideas - earlytimes.in
Royalty Pharma PLC $RPRX Shares Purchased by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
Is Royalty Pharma plc reversing from oversold territoryJuly 2025 Sentiment & Stepwise Trade Execution Plans - newser.com
Impact Partnership Wealth LLC Purchases 12,329 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Assessing Royalty Pharma (RPRX) Valuation After Recent Momentum in 2024 - Sahm
What’s the recovery path for long term holders of Royalty Pharma plcTrade Exit Summary & Free Safe Entry Trade Signal Reports - newser.com
What indicators show strength in Royalty Pharma plcJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
Why retail investors pile into Royalty Pharma plc stockQuarterly Trade Report & AI Forecasted Entry and Exit Points - newser.com
0.35%
1.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):